跳至主要内容
临床试验/JPRN-UMIN000004589
JPRN-UMIN000004589已完成1 期

Phase I radiaition dose escalation study of intensity-modulated radiotherapy with end-exhalation breath-hold technique, combined with full-dose gemcitabine for patients with locally advanced pancreatic cancer. - Breath-hold IMRT for pancreatic cancer: radiation dose escalation study

Department of Therapeutic Radiology, Kyoto University Hospital0 个研究点目标入组 18 人开始时间: 2010年11月19日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with active double cancer (double cancer with no more than 5-year disease-free period. However, carcinoma in situ judged to be cured by local treatment, or intra-mucosal cancer-equivalent lesion are not to be included in active double cancer). 2) Patients with active bacterial infection requiring treatment. 3) Patients with severe cardiac disease 4) Patients with severe drug allergy history 5) Patients with unstable and uncontrollable diabetic mellitus, hypertension, kidney disease, liver disease. 6) Patients with intersitial pneumonia or pulmonary fibrosis detectable on chest radiography 7) Women during pregnancy or breast-feeding, or patients who wish pregnancy 8) Patients that physicians consider inappropriate for this study.

研究者

发起方
Department of Therapeutic Radiology, Kyoto University Hospital

相似试验

Phase I radiaition dose escalation study of... | 临床试验